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Abstract
BACKGROUND AND PURPOSE: To determine the efficacy of the ACTIVLIM-
Stroke questionnaire in detecting changes in functional status of stroke patients.
METHOD: Sixty-eight Benin and Belgian stroke patients participated in this
2-month longitudinal study, involving baseline and follow-up assessments.
Outcome measures combined ACTIVLIM-Stroke questionnaire, Barthel Index
(BI), 6-minute-walk test (6MWT) and modified Rankin scale (MRS).
Responsiveness of ACTIVLIM-Stroke was investigated through different
methodological approaches and compared with BI, 6MWT and MRS. Statistical
analyses were performed using the paired t tests, effect size (ES) and correlation
tests. RESULTS: ACTIVLIM-Stroke detected changes in the whole sample
(p<0.001, ES=0.78) and even in a subgroup of patients (p<0.001, ES=0.29) that
were classified as stable according to the MRS. Moreover, ACTIVLIM-Stroke
permitted the classification of patients into more discriminative groups, including
those showing an important improv...
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ABSTRACT
Background and purpose To determine the efﬁcacy
of the ACTIVLIM-Stroke questionnaire in detecting
changes in functional status of stroke patients.
Method Sixty-eight Benin and Belgian stroke patients
participated in this 2-month longitudinal study, involving
baseline and follow-up assessments. Outcome measures
combined ACTIVLIM-Stroke questionnaire, Barthel Index
(BI), 6-minute-walk test (6MWT) and modiﬁed Rankin
scale (MRS). Responsiveness of ACTIVLIM-Stroke was
investigated through different methodological approaches
and compared with BI, 6MWT and MRS. Statistical
analyses were performed using the paired t tests, effect
size (ES) and correlation tests.
Results ACTIVLIM-Stroke detected changes in the
whole sample (p<0.001, ES=0.78) and even in a
subgroup of patients (p<0.001, ES=0.29) that were
classiﬁed as stable according to the MRS. Moreover,
ACTIVLIM-Stroke permitted the classiﬁcation of patients
into more discriminative groups, including those showing
an important improvement (p<0.001, ES=1.87), a slight
but non-clinically meaningful improvement (p<0.001,
ES=0.38), and no improvement (p=0.1, ES=0.11),
demonstrating its high sensitivity to change.
Furthermore, there were concordant relationships
between ACTIVLIM-Stroke change and any observed
changes in BI, 6MWT and MRS scores (r≥0.50,
p<0.001), conﬁrming the external responsiveness of
ACTVLIM-Stroke.
Conclusions ACTIVLIM-Stroke showed good
responsiveness and can detect accurately clinical changes
in the functional status of stroke patients. The BI and
the 6MWT were also responsive and may provide
complementary information while investigating change in
functional status. However, in addition to being highly
sensitive to change, ACTIVLIM-Stroke presents signiﬁcant
methodological advantages for quantifying functional
changes in stroke patients.
INTRODUCTION
Stroke is prevalent worldwide and is a leading
cause of death and disability.1 2 The effects of
stroke on the victim’s quality of life are multifa-
ceted and generally more pronounced in the phys-
ical dimension, on cognition, language and mood.
As described by the International Classiﬁcation of
Functioning, Disability and Health framework, efﬁ-
cient management of poststroke patients requires
global assessment, which accounts for impairments,
activity limitations and restriction of participation,
while also considering personal and environmental
factors.3 This global assessment supposes the
measurement of manifest and latent relevant vari-
ables, the latter often requiring the use of patient-
reported outcome measures. Acquiring accurate
information regarding functional recovery after
stroke is essential, as it serves as a baseline for
healthcare planning and facilitates therapeutic
guidelines. Functional recovery after stroke is gen-
erally evaluated using scales that are usually incor-
porated into clinical trials and are routinely used
during clinical practice.4
ACTIVLIM-Stroke is a self-reported Rasch-built
questionnaire that measures the ability of stroke
patients to perform daily living activities. It com-
prises 20 items and considers various aspects of
activity limitations.5 It offers the advantage of
cross-cultural validity between African and
European contexts. Its validation in these contexts
makes ACTIVLIM-Stroke a powerful tool for
advancing stroke rehabilitation in multicentric
studies. It also shows excellent psychometric prop-
erties, including validity, reliability, unidimensional-
ity and invariance. However, its ability to reveal
change over time has not yet been determined.
Turner et al6 reported that an instrument measur-
ing health status should be responsive to changes.
Consequently, responsiveness, which reﬂects the
ability of a questionnaire to detect changes over time,
is an important psychometric quality and an essential
criterion for instrument selection when measuring
stroke patient function. Therefore, studies that evalu-
ate the responsiveness of ACTIVLIM-Stroke measure
are warmly required.
This study investigates the responsiveness of
ACTIVLIM-Stroke in comparison with selected
well-known outcome measures, such as the Barthel
Index (BI) and the 6-minute walk test (6MWT).
METHODS
Study design
We performed a 2-month longitudinal study involv-
ing baseline and follow-up assessments. Sixty-eight
stroke patients (mean age 58.52±12.33 years old;
poststroke duration 6.86±11.63 months; sex 53%
female and 47% male) were recruited from the
Rehabilitation Departments in Benin and Belgium.
Subjects were eligible for inclusion if they had
experienced a stroke event at least 2 weeks prior to
examination, were undergoing rehabilitation or
not, scored 24 or more on the Mini Mental State
Examination and freely agreed to participate.
Functional status information was collected at base-
line and follow-up time points.
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The study was approved by the Ethics Committee of the
Université catholique de Louvain in Belgium and the local ethics
committees of the participating caregiver centres and hospitals
in Benin. Each participant signed an informed consent form
prior to inclusion in the study.
Patient assessment
Functional status was measured using a variety of instruments,
combining patient-reported and clinician-reported anchors with
observed performance. The primary outcome measure was
ACTIVLIM-Stroke. Secondary outcome measures were the BI
and the 6MWT. The BI is one of the most widely used generic
and ordinal scales that measure severity of disability in daily life.
It measures a range of activity domains such as communication,
eating, self-care, mobility and transfer through 10 items.7 The
6MWT is a performance test that evaluates walking endurance;
it consists in recording the distance (m) a subject walked in
6 min.8 This test is demonstrated to reﬂect people functional
status.9 10 Participants performed the 6MWT by walking as
quickly as possible on a ﬂat ground square path with a 50–85 m
perimeter marked on the ﬂoor. They were allowed to stop and
rest as necessary. Patients were informed of the time after 2, 4
and 5 min, and the distance walked was recorded to the nearest
metre. The higher the score after each outcome measure, the
better the functional status of the patient. As such, a positive dif-
ference between the second and ﬁrst scores reﬂects a positive
clinical change.
In addition to the BI and 6MWT, the modiﬁed Rankin scale
(MRS), which is an assessment of overall disability, was employed
to characterise the change in health status of the participants over
the 2-month period. This clinician-rated scale categorises the
severity of disability based on observation, ranking patients in
seven different levels from ‘no symptoms at all’ to ‘dead’. An
increasing MRS score indicates worsening status.11
Responsiveness investigation
Analyses were conducted using three approaches: global, group
and individual. The global approach consisted of statistically
comparing patient baseline scores with those reported at the
2-month follow-up. The group approach allowed investigation
of responsiveness indices by patient groups classiﬁed as
improved, stable or deteriorated according to their MRS scores
over the study period. Finally, the individual approach evaluated
changes in the functional status of each patient by applying the
following formula12:
t score ¼ m2 m1ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
(SE2)2 þ (SE1)2
p
m1 and m2 represented the patient’s functional status measures,
respectively, at baseline (time 1) and follow-up (time 2). SE1
and SE2 correspond to their respective associated SE of mea-
surements at time 1 and time 2. The t score approximately
follows a standardised normal distribution such that a patient
with a t score above 1.96 showed important improvement,
while a patient with a t score below −1.96 was signiﬁcantly wor-
sening.12 Patients were divided into ﬁve classes according to
their t score signiﬁcance limits: important deterioration (t score
<−1.96), slight deterioration (−1.96≤ t score <0), no change (t
score=0), slight improvement (0< t score ≤1.96) and important
improvement (t score >1.96).
Analysis of internal responsiveness to change was performed
by comparing the follow-up data with baseline data using a
paired t test and effect size (ES) where applicable. The ES is cal-
culated as the ratio between the mean change and the SD of the
baseline score.13 Analysis of external responsiveness was evalu-
ated by examining the relationships and concordance between
ACTIVLIM-Stroke change and any observed changes in the BI
and 6MWT scores. The magnitude of change was interpreted
according to Cohen’s classiﬁcation, which describes change as
non-signiﬁcant (ES<0.2), small (0.2≤ES<0.5), moderate
(0.5≤ES<0.8) and large (ES≥0.8).14
RESULTS
In terms of internal responsiveness, the mean change in the
68-subject cohort was calculated and the statistical signiﬁcance
was tested based on a paired t test and a signed rank test,
respectively, for linear and ordinal-type instruments (table 1).
ACTIVLIM-Stroke revealed a signiﬁcant positive change
(p<0.001), indicating that the overall sample experienced a
general health improvement between time 1 and time 2. The ES
was 0.78, which corresponded to a large clinical change. The
clinicians’ ratings of overall disability using the MRS showed
that 35 patients (mean poststroke delay of 2.01±2.6 months)
improved and that 32 patients (mean poststroke delay of 10.3
±7.7 months) were stable, while one deteriorated. As only one
patient was rated as deteriorated, the responsiveness analysis by
group approach was undertaken with the improved and stable
groups (table 2). In the improved group, ACTIVLIM-Stroke
conﬁrmed a signiﬁcant and large positive change (p<0.001;
ES=0.95). In the stable group, ACTIVLIM-Stroke also detected
signiﬁcant changes (p<0.001, ES=0.29); however, this change
was considered minor given the small ES.
Analyses based on an individual approach (ﬁgure 1) revealed
that 8 had a t score between −1.96 and 0, 4 had a t score of 0,
25 had a t score between 0 and 1.96, and 31 patients had a t
score above 1.96. This distribution showed that in the group of
patients qualiﬁed as stable by clinicians according to MRS
change score, some had experienced small improvement that
was not detectable by MRS. As such, patients were classiﬁed
into three different groups according to the magnitude of their
change as follows: (1) importantly improved (n=31), (2) non-
Table 1 Responsiveness analysis following a global approach (n=68)
Change
Time 1 Time 2 Mean±SD 95% CI of mean p Value ES
ACTIVLIM-Stroke (logit), mean±SD 0.77±2.09 2.41±2.19 1.64±1.73 1.22 to 2.06 <0.001 0.78
6-minute walk test (m), mean±SD 127.57±126.02 192.24±157.46 64.67±107.43 38.66 to 90.67 <0.001 0.51
Barthel Index, median (P25; P75) 80 (60–90) 92.5 (80–100) – – <0.001 –
Modified Rankin scale, median (P25; P75) 3 (2–4) 2 (1.5–3) – – <0.001 –
ES, effect size; P, percentile; time 1, baseline; time 2, follow-up.
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clinically meaningfully improved (n=25) and (3) not improved
(n=12) (table 3).
Correlations in external responsiveness were observed
between scores changes from all instruments. There was a
strong positive correlation between ACTIVLIM-Stroke change
and BI change (p=0.62, p<0.001), MRS change (p=0.64,
p<0.001) and 6MWT change (r=0.50, p<0.001). Moreover,
measurements obtained from 6MWT, BI and MRS conﬁrmed
the overall improvement detected by ACTIVLIM-Stroke in the
global approach analysis (table 1). BI and 6MWT also demon-
strated a large positive change in the group of patients classiﬁed
as improved according to the MRS (table 2). However, in the
stable group, only the 6MWT conﬁrmed no signiﬁcant change
(p=0.13; ES=0.11). The BI similarly detected a small signiﬁ-
cant improvement, similar to ACTIVLIM-Stroke, conﬁrming the
higher sensitivity of ACTIVLIM-Stroke compared with MRS
(table 2). Furthermore, a strong concordance was observed
between individual self-reported changes based on
ACTIVLIM-Stroke and all other instruments (table 3). Indeed,
in the groups of patients that reported important individual
improvements, all instruments showed signiﬁcant (p<0.001)
and clinically meaningful changes with ESs of 1.87 and 1.09,
respectively, for ACTIVLIM-Stroke and the 6MWT. In the
group that reported a non-clinically meaningful improvement,
all instruments were concordant as they revealed a signiﬁcant
change (p≤0.03). Furthermore, ACTIVLIM-Stroke (ES=0.38)
and 6MWT (ES=0.36) conﬁrmed that these changes were clin-
ically small. Accordingly, in the group that reported no individ-
ual improvement, none of these instruments detected statistical
signiﬁcant change (p≥0.1; ES=0.11). Moreover, the higher the
poststroke delay was, the lower the ACTIVLIM-Stroke mean
change was (ﬁgure 2 and table 3), demonstrating a relationship
between functional recovery and poststroke duration.
DISCUSSION
This study evaluated the ability of the ACTIVLIM-Stroke ques-
tionnaire to measure relevant changes in stroke patients in com-
parison with two widely used outcome measures: the BI and the
6MWT. Results showed that ACTIVLIM-Stroke is very sensitive
to change and can accurately measure minor and clinically rele-
vant changes in patients over time.
Our analyses showed that changes in ACTIVLIM-Stroke were
associated with changes in BI and 6MWT. Data obtained from
ACTIVLIM-Stroke, BI and 6MWT all demonstrated that the
functional status of the whole sample signiﬁcantly improved
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Figure 1 Distribution of patients (n=68) according to the magnitude
of ACTIVLIM-Stroke change as indicated by their t scores.
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after 2 months. ACTIVLIM-Stroke seemed to be more respon-
sive than BI or 6MWT as it revealed a higher ES. However, this
global approach may mask important information as data were
pooled together, allowing no distinction between the patients
that made signiﬁcant improvements and those who did not. As
such, despite the overall signiﬁcant improvement, there were
wide variations in the magnitude of change among the 68
stroke patients analysed. To rectify this, patients were classiﬁed
into improved or stable groups based on the MRS as determined
by clinicians. This group approach analyses revealed that
patients who were classiﬁed as improved showed signiﬁcant
improvement with ACTIVLIM-Stroke, BI and 6MWT. In the
stable group, only 6MWT showed no signiﬁcant changes.
ACTIVLIM-Stroke and BI detected signiﬁcant, yet small changes
in this group, suggesting that they may be more sensitive than
MRS and 6MWT. Although MRS is a valuable instrument for
assessing stroke patient global outcomes,15 yet it demonstrates a
lack of sensitivity to small changes.16 This can be explained by
the fact that it is a single-item scale that allows only a broad
description of a patient’s overall status through a seven-level
response format (from ‘no symptoms at all’ to ‘dead’). The
ACTIVLIM-Stroke and the BI comprised 20 and 10 non-
redundant items, respectively. As such, they capture more details
than the MRS, permitting more discrimination and conse-
quently more sensitivity to small changes. In addition, the
6MWT, which was designed to reﬂect functional recovery in
chronic disabled people,9 10 is a speciﬁc test of walking capacity.
It measures only part of physical performance (ie, locomotion)
and does not evaluate other subdomains of functional status
and, therefore, may not be sensitive to small changes occurring
in a subdomain other than locomotion. This could justify why
6MWT is less sensitive than the ACTIVLIM-Stroke question-
naire. Similarly, BI exhibits less sensitivity compared with
ACTIVLIM-Stroke. This result can be due to the fact that BI
measures basic ADL with less detail compared with other com-
monly used activity of daily living (ADL) scales such as the
Functional Independence Measure (FIM) or the Frenchay
Index. It is possible that FIM appears to be as sensitive as the
ACTIVLIM-Stroke; however, this hypothesis still needs to be
investigated.
As shown in previous studies,17 18 an individual approach,
such as the one taken in the present study, provides essential
information regarding responsiveness, given that individuals in a
group do not equally experience the mean change of the group.
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Figure 2 Groups of patients according to individual self-reported
change.
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Here, an individual approach analysis allowed the investigation
of how each of the 68 patients improved after the 2-month time
frame. Based on their individual self-reported activity limita-
tions, patients could then be classiﬁed not only as improved or
stable, but also in more discriminative groups as having import-
antly or slightly improved, or showing no improvement. This
indicates that, compared with the MRS, ACTIVLIM-Stroke has
a greater ability to detect change. It is important to note that
the individual approach could only be applied with
ACTIVLIM-Stroke, which, like any Rasch-built scale, provides
the individual’s measures with associated SEs. Indeed, using the
approach developed by Wright and Stone,12 the SEs are an
essential requirement for investigating statistically signiﬁcant
individual changes.
The degree of agreement between changes measured by dif-
ferent instruments is essential in responsiveness investigations.
This study showed that the individual change reported by
patients themselves matched the change measured by other
instruments, conﬁrming the external responsiveness of
ACTIVLIM-Stroke. 6MWT and BI revealed important signiﬁ-
cant mean changes in the group of patients who reported
having importantly improved. They showed only a small mean
change in the patient group reporting non-clinically meaningful
improvement, while they showed no signiﬁcant change in the
group reporting no improvement over the 2-month period.
These results also demonstrated that patient’s self-report scores
related well to clinician-based scores and observed perfor-
mances, conﬁrming previous ﬁndings.19 20
In addition, our selected outcome measures covered a variety
of assessment methods. While BI and MRS are clinician-
reported anchors, ACTIVLIM-Stroke is a self-reported question-
naire and 6MWT is a performance-based test. Combining all of
these outcome measures allowed a multidimensional assessment
of change as determined by the patient’s own judgement, the
clinician’s perception and observed performance.
Our results conﬁrmed that ACTIVLIM-Stroke, BI and 6MWT
can be used to monitor the functional recovery of patients
undergoing rehabilitation. Nonetheless, it appeared that
ACTIVLIM-Stroke showed a greater sensitivity to change. BI
and 6MWT present some shortcomings compared with
ACTIVLIM-Stroke. First, BI has previously been described as
less sensitive to change at extremes of disability (ﬂoor and
ceiling effects).16 21 Second, being an ordinal scale, BI restricts
statistical investigations. For example, analysis should be limited
to non-parametric statistics with no possibility to compute mean
changes and ESs. Third, both BI and 6MWT do not provide
associated SE to individual measures, making statistical investi-
gations of responsiveness at individual level impossible. More
importantly, individual approach of clinical change is essential
in clinical trial since it has been demonstrated that ES calcula-
tions are potentially misleading indicators of rating scale respon-
siveness at the group comparison level so that, when comparing
various instruments, ES computed at group level should be
interpreted carefully.22 Therefore, it is important to analyse
change at individual level since changes that have a meaning in
groups may not be meaningful in individuals.23 Moreover, an
outcome measure that permits decision making regarding the
signiﬁcance of a change on an individual basis is extremely
useful in clinical practice, where each patient constitutes his
own control over time. The linear characteristics of
ACTIVLIM-Stroke and the fact that it provides individual SEs
allow thorough investigations of its responsiveness in global,
group and individual approaches. This particular advantage
makes ACTIVLIM-Stroke a recommendable tool in clinical trial
and practice. As it is time efﬁcient, this scale is also a reasonable
option when tracking changes in stroke patients’ functional
status and may provide assistance when making decisions
regarding the efﬁcacy of interventions or treatments.
It has been argued that the use of more sensitive measurement
instruments would increase the evidence on the efﬁcacy of
rehabilitation treatment.16 24 A good health status outcome
measure should allow the detection of small changes over time.
This property is essential when analysing the efﬁcacy of a treat-
ment or when monitoring the variations in the health status of a
cohort of patients. This study conﬁrms that distribution-based
methods and anchor-based approaches are complementary in
responsiveness investigations.4 25 It also shows that global scales
with single item are much less sensitive to changes in disability
than the activity of daily living scales.16 Our results also high-
lighted that, in this cohort, acute and subacute stroke patients
experienced better improvement than chronic stroke patients
(ﬁgure 2). This indicated that functional recovery might be
more important in the phases immediately after stroke than in
the chronic phase. This observation is supported by existing evi-
dence that generally describes functional poststroke recovery as
slowing down in chronic phase.26–28
Finally, instruments that are responsive in both severe and
mild strokes are required for patients’ clinical follow-up.
Indeed, due to ceiling effect, many available scales are useless in
clinical trials that enrol patients with mild disease conditions. In
this study, we have demonstrated the high sensitivity to change
of ACTIVLIM-Stroke in patients with relatively moderate dis-
ability as revealed by the baseline scores, conﬁrming its useful-
ness as outcome measure for clinical practice and trial.
Nevertheless, further studies could analyse the responsiveness of
ACTIVLIM-Stroke in patients with more severe disability. It
would also be useful to investigate how responsive is the
ACTIVLIM-Stroke questionnaire in comparison to other com-
monly used scales such as the Functional Independence Measure
and the Frenchay Activity index.
CONCLUSION
In summary, different statistical indices and methodological
approaches were combined to investigate the comparative
responsiveness of ACTIVLIM-Stroke, BI and 6MWT. Our
results showed that all these instruments are responsive and can
be used to measure clinical changes in the functional status of
stroke patients. ACTIVLIM-Stroke presents good internal and
external responsiveness and can detect even small changes. This
scale appears to be more sensitive than BI and 6MWT, and
offers signiﬁcant methodological and statistical advantages for
investigating change.
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